Key Metrics
CiteScore 

4
Eigenfactor 

0.001 - 0.005
H-Index 

64
Impact Factor 

< 5
Scite Index 

0.87 5-Year SI

SJR 

Q2Oncology

SNIP 

1.07
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Oncology
Journal of Oncology Journal Specifications
| Overview | |
| Publisher | Hindawi |
Planning to publish in Journal of Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Oncology
RETRACTION: Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5\u2010Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta\u2010Analysis and Systematic Review
- 7 Aug 2026
- Journal of Oncology
Correction to \u201cInitial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines\u201d
- 29 Jul 2026
- Journal of Oncology
RETRACTION: Nrf3 Promotes 5\u2010FU Resistance in Colorectal Cancer Cells via the NF\u2010\u03baB/BCL\u20102 Signaling Pathway In Vitro and In Vivo
- 16 Jul 2026
- Journal of Oncology
Correction to \u201cClusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF\u2010\u03baB\u2010Dependent Mechanism\u201d
- 31 May 2026
- Journal of Oncology
Title not available
- 1 Jan 2026
- Journal of Oncology
RETRACTION: P4HA2 Promotes Epithelial-to-Mesenchymal Transition and Glioma Malignancy through the Collagen-Dependent PI3K/AKT Pathway.
- 1 Jan 2026
- Journal of oncology
RETRACTION: Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5\u2010Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta\u2010Analysis and Systematic Review
- 7 Aug 2026
- Journal of Oncology
Correction to \u201cInitial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines\u201d
- 29 Jul 2026
- Journal of Oncology
RETRACTION: Nrf3 Promotes 5\u2010FU Resistance in Colorectal Cancer Cells via the NF\u2010\u03baB/BCL\u20102 Signaling Pathway In Vitro and In Vivo
- 16 Jul 2026
- Journal of Oncology
Correction to \u201cClusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF\u2010\u03baB\u2010Dependent Mechanism\u201d
- 31 May 2026
- Journal of Oncology
Title not available
- 1 Jan 2026
- Journal of Oncology
RETRACTION: P4HA2 Promotes Epithelial-to-Mesenchymal Transition and Glioma Malignancy through the Collagen-Dependent PI3K/AKT Pathway.
- 1 Jan 2026
- Journal of oncology